C62-M4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C62-M4, covering 2025-08-24 to 2025-08-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3M4 in Persons With HIV-1 Suppressed on ART [Phase 1]